Recursion Pharmaceuticals reported Q3 2026 revenue of US$18.55 million and a net loss of US$119.04 million, while ...
Improvement" Take on a Life of Its Own?"If we keep having an AI improve itself, wouldn't explosive evolution (Recursive ...
In a thought-provoking exploration centered on Sam Altman’s pivotal perspective, "Who Decides How Much Smarter AI Should Be ...
Mianbi RSI stands as a cutting-edge innovation featuring independently developed AI operators that fundamentally reshape the ...
On November 2, 2026, a blog post published by an MIT research team became a major topic among AI researchers. It claimed that ...
Tencent Hunyuan releases Hy 4, becoming one of the world's leading opensource models. Hy 4 introduces visual understanding ...
Recursion Pharmaceuticals (NASDAQ:RXRX) has counted Nvidia as an investor since 2023 when Jensen Huang's company invested ...
Together AI builds an agentic compiler to try and bring recursive self improvement capabilities to open source models.
KI-Unternehmen sprechen von Maschinen, die sich selbst weiterentwickeln. Ist das Eigenwerbung oder eine echte Möglichkeit – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results